bioLytical Laboratories Named B.C. Exporter of the Year
November 26, 2019 09:00 ET
|
bioLytical Laboratories Inc.
Award recognizes bioLytical as “the best of the best” for its achievements as an export company, and its contribution to the B.C. economy RICHMOND, British Columbia, Nov. 26, 2019 (GLOBE NEWSWIRE)...
INSTI now available for expanded point-of-care use in Canada
September 19, 2019 09:00 ET
|
bioLytical Laboratories Inc.
RICHMOND, British Columbia, Sept. 19, 2019 (GLOBE NEWSWIRE) -- bioLytical Laboratories, a world leader in rapid diagnostic tests for infectious diseases, is pleased to announce that the INSTI HIV-1...
New Report From Grantmakers In Aging Explores Experiences and Unique and Unmet Needs of Older People Living With HIV/AIDS
September 12, 2019 16:31 ET
|
Grantmakers In Aging
WASHINGTON, Sept. 12, 2019 (GLOBE NEWSWIRE) -- For years, it seemed unlikely that most people living with HIV or AIDS would live long lives, but much has changed and HIV/AIDS must now be regarded as...
Intravenous Immunoglobulin (IVIG) Market To Reach USD 15.67 Billion By 2026 | Reports And Data
May 28, 2019 12:38 ET
|
Reports And Data
The rapid increase in neurological disorders, increase in geriatric population, and continuous increase in the number of patients are fueling the market growth. Market Size – USD 9.43 Billion in...
GeoVax Reports 2019 First Quarter Financial Results and Highlights Corporate Development Progress
May 14, 2019 10:23 ET
|
GeoVax, Inc.
ATLANTA, May 14, 2019 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVXD), a biotechnology company developing human vaccines, today announced its financial results for the three months ended March...
GeoVax Announces Reverse Stock Split
May 03, 2019 08:59 ET
|
GeoVax, Inc.
1:500 Reverse Split Effective May 2, 2019;Ticker Symbol Changed to GOVXD for 20 Days ATLANTA, GA, May 03, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX) today...
AXIM® Biotech Enters Services Agreement With CRO to Begin Clinical Studies On Dronabinol and CBD Chewing Gums
April 09, 2019 09:35 ET
|
AXIM BIOTECHNOLOGIES, INC
NEW YORK, April 09, 2019 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (“AXIM”) (“the Company”) (“AXIM® Biotech”) (OTC:AXIM), a world leader in cannabinoid research and development, today...
GeoVax Provides Product Development and Corporate Update
March 11, 2019 09:00 ET
|
GeoVax, Inc.
ATLANTA, GA, March 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines and immunotherapies using its novel viral vector...
GeoVax CEO David Dodd Responds to President Trump’s State of the Union Message
February 06, 2019 10:11 ET
|
GeoVax, Inc.
Applauding HIV Elimination Goals and Encouraging More Resources Toward Vaccine Development ATLANTA, GA, Feb. 06, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX)....
EGPAF Welcomes Passage of PEPFAR Extension Act of 2018
November 29, 2018 13:50 ET
|
Elizabeth Glaser Pediatric AIDS Foundation
Washington, D.C., Nov. 29, 2018 (GLOBE NEWSWIRE) -- The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) commends the U.S. House and Senate for passing H.R. 6651: PEPFAR Extension Act of 2018....